Author(s):
Dhatchanamoorthi N, Raju Kamaraj
Email(s):
dhatchandsna16@gmail.com
DOI:
10.5958/0974-360X.2020.00975.0 
Address:
Dhatchanamoorthi N, Raju Kamaraj
Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Kanchipuram, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 11,
Year - 2020
ABSTRACT:
In pharmaceutical industry, the regulatory compliance of computer system is increasing their importance. The regulation required to maintain a record for its safety, strength, efficacy, and quality for the substance. It establishing documented evidence to provide a high degree of assurance in a way of software or hardware which gives a fulfillment in line with the regulatory guidelines for certain industries mainly the 21 CFR part 820 and 21 CFR part 210 and 211 is applied to pharmaceutical product and is also applied to the medical device. The given life cycle model included the stage of 1. Planning, 2. Specification, 3. Programing, 4. Commissioning, 5. Testing, 6. Documentation, 7. Operating, 8. Monitoring and 10. Modifying. The V- Module supports structured testing it is very essential for successful validation. In this computer system validation content attach with the user requirement specification knowledge and a way to avoid a failure in computer system validation planning and many sources about this CSV are clearly discussed in this validation document.
Cite this article:
Dhatchanamoorthi N, Raju Kamaraj. An Overview on Challenges and Importance of Computer system Validation in Pharmaceutical Industry. Research J. Pharm. and Tech. 2020; 13(11):5591-5594. doi: 10.5958/0974-360X.2020.00975.0
Cite(Electronic):
Dhatchanamoorthi N, Raju Kamaraj. An Overview on Challenges and Importance of Computer system Validation in Pharmaceutical Industry. Research J. Pharm. and Tech. 2020; 13(11):5591-5594. doi: 10.5958/0974-360X.2020.00975.0 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-11-90
REFERENCE:
1. CFR, 21 CFR, Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals, sections 21 I .22: Proposed Rules, vol. 61. Federal Register, pp., 1996; 20104-20115.
2. Potdar M.A, cGMP for Pharmaceuticals, Pharmaceutical Validation, 3rd edition, Nirali Prakashan, Pune, 437 – 450.
3. Guidelines for Process Validation of Pharmaceutical Dosage Forms. Saudi Food and Drug Authority, Kingdom of Saudi Arabia, 2010.
4. Ludwig Huber,’ Analytical Instrument Qualification and System Validation’, Agilent Technologies, 2009, Publication Number 5990-3288EN, pp-40-44.
5. Nash R. A., Wachter A. H., Pharmaceutical Process Validation, An International 3rd Edition, Revised and Expanded, Marcel Dekker, New York, March., 2003; 129: 31-57.
6. Kavita, Khurana G, Chaudhary S. Process Validation of Solid Dosage Form: A Review. Pharma Science Monitor. 4 (4); 2013: 390- 391.
7. Dr. Keyur BA, Khushboo DS, Sushma PY, Hetal SP, Chetan BP. Overview of Validation and Basic Concepts of Process Validation. Scholars Academic Journal of Pharmacy.3 (2); 2014:178-190.
8. Andreas Hoffmann, Jacqueline I Gihny-Simonius, Marcel Plattner, Vanja Schmidli Vckovski, Christian Kronseder, ―Computer system validation: An overview of official requirements and standards‖, Pharmaceutics Acta Helvetiae., 1998; 72: 317-325.
9. Nash RA, Wachter AH. In Pharmaceutical Process Validation. Third Edition; Revised and Expanded. Marcel Dekker Inc., New York. 1993.
10. Quality Management System – Process Validation Guidance GHTF/SG3/N99-10. 2004. (Edition 2).
11. Loftus BT. The Regulatory Basis for Process Validation. Pharmaceutical Process Validation. Vol. 23, Marcel Dekker, New York. 1984.
12. Shoaib Alam Md. Pharmaceutical Process Validation: An Overview. Journal of Advanced Pharmacy Education and Research. 2 (4); 2012: 185-200.
13. Harpreet K, Gurpreet S, Nimrata S. Pharmaceutical Process Validation: A Review. Journal of Drug Delivery and Therapeutics. 3 (4); 2013:189-194.
14. Pankaj V, Satheesh Madhav NV, Gupta VK. A review article on pharmaceutical validation and process controls. The Pharma Innovation.1 (7); 2012: 51-60.
15. EC, 1989. Guide to Good Manufacturing Practice (GMP). In: The Rules Governing Medicinal Products in the European Community, vol. 4. Amended, Good Manufacturing Practice for Medicinal Products in the European Community. January, pp. 13-165.
16. Dr. Sohan S. Chitlange, Dr. Pravin D. Chaudhari, Mr. Ajinath E. Shirsath, Dr. Jaiprakash N. Sangshetti, Pharmaceutical Validation‖ First Edition, Suyog Publication and Distributors Pvt. Ltd. 8.1-8.11.
17. Sharon Strause ―Computer System Validation—Definition and Requirements‖ Originally published in the spring 2009 issue of Journal of Validation Technology, pp-1-5.
18. CFR part 11 electronic records; electronic signatures; final rule; department of health and human services, food and drug administration CFR part 11 electronic records; electronic signatures; final rule; department of health and human services, food and drug administration; federal register, vol. 62, no.54, march 20, 1999, Page No. 1027-1094
19. Computer systems validation: quality assurance, risk management, and regulatory compliance for the pharmaceutical and healthcare industry GAS Wingate Wingate, G.A.S. (2004), 'computer systems validation: quality assurance, risk management, and regulatory compliance for the pharmaceutical and healthcare industry', Interpharm press.
20. Sharma A, Saini S. Process Validation of Solid Dosage Form: A Review. International Journal of Research in Pharmacy and Science. 3 (2); 2013: 12- 30.
21. Validation of Solid Dosage Forms the FDA view, 1989; 15(6-7): 1119-1133.
22. World health organization. Guidelines on the validation of manufacturing process for pharmaceutical products. Geneva.1993
23. Potdar MA. Pharmaceutical Quality Assurance. Nirali Prakashan, Pune.2009; 2nd ed: pp. 8.6-8.20.
24. Patel RC, Bhuva CK, Singh RP, Dadhich A, Sharma A. Pharmaceutical Process Validation, Pharmatutor – ART – 1053.
25. WHO Expert Committee on Specifications for Pharmaceutical Preparations. WHO technical report, series no. 863 – 34th report, Annex 6 – GMP: Guidelines on the validation of manufacturing processes.
26. FDA Guidance Update: process Validation: General Principles and Practices; version 01; 2009.
27. Guidance for Industry on general principles and practices of process validation; US Department of Health and Human Services, Food and Drug Administration. 2011.
28. Rockville MD. Guideline on General Principles of Process Validation. U.S. Food and Drug Administration, U.S. FDA: 2010.
29. Validation Guidelines for Pharmaceutical Dosage Form; Health products and Food branch Inspectorate, Canada. 2009.
30. Good Manufacturing Practices for Pharmaceutical products, WHO Expert Committee on Specifications for Pharmaceutical Preparations, 32nd Report, WHO Technical Report Series no. 823, WHO, Geneva. 1992; 14-96.